Top Markets
Coin of the day
American Bio Medica Corporation American Bio Medica Corporation

American Bio Medica Corporation

ABMC
Rang in Aktien #42104
American Bio Medica Corporation (ABMC) specializes in the development and... American Bio Medica Corporation (ABMC) specializes in the development and distribution of lateral flow immunoassay tests, primarily designed for the rapid detection of drugs in both urine and oral fluid samples. Their extensive range of urine-based drug screening solutions includes the Rapid Drug Screen, capable of identifying between 2 and 10 substances; the RDS InCup, a convenient testing cup detecting 1 to 12 drugs; Rapid TOX, a cassette-based test for 1 to 10 drugs; and the Rapid TOX Cup II, another cup format that screens for 1 to 16 different drugs. Each product aims to swiftly determine the presence or absence of illicit substances. Furthermore, ABMC provides OralStat, an oral fluid drug test, available also in private-labeled versions. Beyond its proprietary offerings, the company acts as a distributor for various other products focused on detecting substances of abuse and identifying specific infectious diseases. The company extends its expertise to non-affiliated diagnostic firms, offering contract services that encompass the manufacturing, assembly, and packaging of diagnostic strips. Serving a diverse clientele, ABMC caters to the needs of rehabilitation and drug treatment centers, pain management clinics, general clinical settings, government agencies, and employment/workplace screening programs. Its operations span across the United States, Europe, the Asia Pacific region, and South America. Founded in 1986 as American Micro Media, Inc., the company adopted its current name, American Bio Medica Corporation, in September 1992. Its corporate headquarters are situated in Kinderhook, New York.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-07-02
Marktkapitalisierung
$4.81K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel American Bio Medica Corporation (ABMC)

Kategorie

Operative Marge für American Bio Medica Corporation (ABMC)
Operative Marge zum 2026 TTM: 0.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von American Bio Medica Corporation beträgt die aktuelle operative Marge (TTM) 0.00%. Am Ende des Jahres 2026 lag die operative Marge bei 0.00%.
Historie der operativen Marge von American Bio Medica Corporation von 2026 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
Nicht genügend Daten für die angegebenen Daten.
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
17.69% -
US
20.42% -
US
0.00% -
CN
31.63% -
US
-12.97% -
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.